Skip to main content
SpringerLink
Log in

Prevention

  • Chapter
Geriatric Medicine

Conclusion

As the quantity of prevention-related information increases and dissemination becomes quicker and more widespread, shared decision making between clinician and patient will become increasingly important. Availability of sites beyond the physician’s office—the Internet, the workplace, senior centers, and schools, for example—will facilitate broader access to disease prevention and health promotion measures. As more individuals live longer and more active lives, attention to lifestyle habits, quality of life issues, risk factors for diseases, and genuine health promotion activities will demand more attention in the disease prevention/health promotion arena. The medical community, however, will need to be vigilant in its surveillance of “new break-through prevention measures” to guard the general older public from the unscientific claims of those purporting to practice “anti-aging” medicine (see Chapter 62).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 379.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. U.S. Department of Health and Human Services. Healthy People 2000: National Health Promotion and Disease Prevention Objectives. DHHS pub PHS 91-50213. Washington, DC: Government Printing Office; 1991.

    Google Scholar 

  2. Fries JF, Koop CE, Beadle CE, et al. Reducing health care costs by reducing the need and demand for medical services. N Engl J Med. 1993;329:321–325.

    Article  PubMed  CAS  Google Scholar 

  3. Patterson C, Chambers LW. Preventive health care. Lancet. 1995;345:1611–1615.

    Article  PubMed  CAS  Google Scholar 

  4. Centers for Disease Control and Prevention. CDC surveillance summaries, Dec. 17, 1999. MMWR. 1999;48(no SS-8).

    Google Scholar 

  5. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMMW. 2000;49:1–38.

    Google Scholar 

  6. Patriarca PA, Weber JA, Parker RA, et al. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA. 1985;253:1136–1139.

    Article  PubMed  CAS  Google Scholar 

  7. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med. 1995;123:518–527.

    PubMed  CAS  Google Scholar 

  8. Couch RB. Drug therapy: prevention and treatment of influenza. N Engl J Med. 2000;343:1778–1787.

    Article  PubMed  CAS  Google Scholar 

  9. Govaert TM, Thijs CT, Masurel N, et al. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA. 1994; 272(21):1661–1665.

    Article  PubMed  CAS  Google Scholar 

  10. Couch RB. Drug therapy: prevention and treatment of influenza. N Engl J Med. 2000;343:1778–1787.

    Article  PubMed  CAS  Google Scholar 

  11. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med. 1995;123:518–527.

    PubMed  CAS  Google Scholar 

  12. Arden NH, Kendal AP, Patriarca PA. Influenza prevention and treatment. In: Managing an Influenza Vaccination Program in the Nursing Home. U.S. DHHS Public Health Services. Atlanta: Centers for Disease Control; 1987:3–7.

    Google Scholar 

  13. Carman WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet. 2000;355(9198):93–97.

    Article  PubMed  CAS  Google Scholar 

  14. Potter J, Stott DJ, Roberts MA, et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis. 1997; 175(1):1–6.

    PubMed  CAS  Google Scholar 

  15. Mast EE, Harmon MW, Gravenstein S, et al. Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2). Am J Epidemiol. 1991;134(9):988–997.

    PubMed  CAS  Google Scholar 

  16. Libow LS, Neufeld RR, Olson E, Breuer B, Starer P. Sequential outbreak of influenza A and B in a nursing home: efficacy of vaccine and amantadine. J Am Geriatr Soc. 1996;44(10):1153–1157.

    PubMed  CAS  Google Scholar 

  17. Schilling M, Povinelli L, Krause P, et al. Efficacy of zanamivir for chemoprophylaxis of nursing home influenza outbreaks. Vaccine. 1998;16(18):1771–1774.

    Article  PubMed  CAS  Google Scholar 

  18. Drinka PJ, Gravenstein S, Schilling M, Krause P, Miller BA, Shult P. Duration of antiviral prophylaxis during nursing home outbreaks of influenza A: a comparison of 2 protocols. Arch Intern Med. 1998;158(19):2155–2159.

    Article  PubMed  CAS  Google Scholar 

  19. Degelau J, Somani SK, Cooper SL, Guay DR, Crossley KB. Amantadine-resistant influenza A in a nursing facility. Arch Intern Med. 1992;152(2):390–392.

    Article  PubMed  CAS  Google Scholar 

  20. Drinka PJ, Gravenstein S, Krause P, et al. Outbreaks of influenza A and B in a highly immunized nursing home population. J Fam Pract. 1997;45(6):509–514.

    PubMed  CAS  Google Scholar 

  21. Bradley SF. Prevention of influenza in long-term-care facilities. Long-Term-Care Committee of the Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol. 1999;20(9):629–637.

    Article  PubMed  CAS  Google Scholar 

  22. Sims RV, Steinmann WC, McConville JH, King LR, Zwick WC, Schwartz JS. The clinical effectiveness of pneumococcal vaccine in the elderly. Ann Intern Med. 1988;108: 653–657. (Published erratum appears in Ann Intern Med. 1988;109(9):762–763).

    PubMed  CAS  Google Scholar 

  23. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 1991;325:1453–1460.

    Article  PubMed  CAS  Google Scholar 

  24. Butler JC, Breimen RF, Compbell JF, Lipman HB, Broome CV, Facklam R. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA. 1993;270:1826–1831.

    Article  PubMed  CAS  Google Scholar 

  25. Farr BM, Johnston BL, Cobb DK, et al. Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study. Arch Intern Med. 1995;155:2336–2340.

    Article  PubMed  CAS  Google Scholar 

  26. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 1991;325(21):1453–1460.

    Article  PubMed  CAS  Google Scholar 

  27. Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam R. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA. 1993;270:1826–1831.

    Article  PubMed  CAS  Google Scholar 

  28. Prevots R, Sutter RW, Strebel PM, et al. Tetanus surveillance—United States 1989–1990. MMWR. 1992:41–49.

    Google Scholar 

  29. Sutter RW, Cochi SL, Brink EW, Sirotkin BI. Assessment of vital statistics and surveillance data for monitoring tetanus mortality, United States, 1979–1984. Am J Epidemiol. 1990;131:132–142.

    PubMed  CAS  Google Scholar 

  30. U.S. Preventive Services Task Force. Adult Immunizations. Guide to Clinical Preventive Services. Baltimore: Williams & Wilkins; 1996:791–814.

    Google Scholar 

  31. Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines on screening and surveillance for the early detection of adenomatous polyps and cancer: update 2001. In: American Cancer Society Guidelines for the Early Detection of Cancer. Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers. Also Update 2001: Testing for Early Lung Cancer Detection. CA Cancer J Clin. 2001;51(1):38–75.

    Article  PubMed  CAS  Google Scholar 

  32. Mandel JS, Church TR, Ederer F. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999;91:434–437.

    Article  PubMed  CAS  Google Scholar 

  33. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–1477.

    Article  PubMed  CAS  Google Scholar 

  34. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised Study of screening for colorectal cancer with faecal-occult-blood test [see comments]. Lancet 1996;348:1467–1471.

    Article  PubMed  CAS  Google Scholar 

  35. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603–1607.

    Article  PubMed  CAS  Google Scholar 

  36. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000;343(3):169–174.

    Article  PubMed  CAS  Google Scholar 

  37. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000;343(3):162–168.

    Article  PubMed  CAS  Google Scholar 

  38. Tinetti ME, Stone L, Cooney L, Kapp MC. Inadequate barium enemas in hospitalized elderly patients. Incidence and risk factors. Arch Intern Med. 1989;149(9):2014–2016.

    Article  PubMed  CAS  Google Scholar 

  39. Gurwitz JH, Noonan JP, Sanchez M, Prather W. Barium enemas in the frail elderly. Am J Med. 1992;92(1):41–44.

    Article  PubMed  CAS  Google Scholar 

  40. Woolf SH. The best screening test for colorectal cancer. N Engl J Med. 2000;343:1641–1643.

    Article  PubMed  CAS  Google Scholar 

  41. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329: 1977–1981.

    Article  PubMed  CAS  Google Scholar 

  42. Rex DK, Johnson DA, Burt R. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol. 2000;95:868–877.

    PubMed  CAS  Google Scholar 

  43. Bond JH. Virtual colonoscopy—promising, but not ready for widespread use. N Engl J Med. 1999;341:1540–1542.

    Article  PubMed  CAS  Google Scholar 

  44. Woolf SH. The best screening test for colorectal cancer. N Engl J Med. 2000;343:1641–1643.

    Article  PubMed  CAS  Google Scholar 

  45. Jansen MC, Bueno-de-Mesquita HB, Buzina R, et al. Dietary fiber and plant foods in relation to colorectal cancer mortality: the Seven Countries Study. Int J Cancer. 1999;81(2):174–179.

    Article  PubMed  CAS  Google Scholar 

  46. Fuchs C, Giovannucci E, Colditz G, et al. Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med. 1999;340:169–176.

    Article  PubMed  CAS  Google Scholar 

  47. Byers T. Diet, colorectal adenomas, and colorectal cancer. N Engl J Med. 2000;342:1206–1207.

    Article  PubMed  CAS  Google Scholar 

  48. Schatzkin A, Lanza E, Corle D, et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med. 2000;342(16):1149–1155.

    Article  PubMed  CAS  Google Scholar 

  49. Alberts DS, Martinez ME, Roe DJ, et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians’ Network. N Engl J Med. 2000;342(16):1156–1162.

    Article  PubMed  CAS  Google Scholar 

  50. Janne PA, Mayer RJ. Chemoprevention of colorectal cancer. N Engl J Med. 2000;342(26):1960–1968.

    Article  PubMed  CAS  Google Scholar 

  51. Minton SE. Chemoprevention of breast cancer in the older patient. Hematol Oncol Clin N Am. 2000;14:113–130.

    Article  CAS  Google Scholar 

  52. Smith-Bindman R, Kerlikowske K, Gebretsadik T, Newman J. Is screening mammography effective in elderly women? Am J Med. 2000;108:112–119.

    Article  PubMed  CAS  Google Scholar 

  53. Smith-Bindman R, Kerlikowske K, Gebretsadik T, Newman J. Is screening mammography effective in elderly women? Am J Med. 2000;108:112–119.

    Article  PubMed  CAS  Google Scholar 

  54. Chu KC, Tarone RE, Kessler LG, et al. Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst. 1996;88:1571–1579.

    PubMed  CAS  Google Scholar 

  55. Kerlikowske K, Barclay J. Outcomes of modern screening mammography. J Natl Cancer Inst Monogr. 1997;63:105–111.

    Google Scholar 

  56. Olsen O, Gotzsche PC. Screening for breast cancer with mammography (Cochrane Review). Cochrane Database Syst Rev. 2110;4;CD001877.

    Google Scholar 

  57. Smith-Bindman R, Kerlikowske K, Gebretsadik T, Newman J. Is screening mammography effective in elderly women? Am J Med. 2000;108:112–119.

    Article  PubMed  CAS  Google Scholar 

  58. Breast cancer screening in older women. AGS Clinical Practice Committee. J Am Geriatr Soc. 2000;48:842–844.

    Google Scholar 

  59. De Parle N. From the Health Care Financing Administration. JAMA. 2000;283(12):1558.

    Article  Google Scholar 

  60. U.S. Preventive Services Task Force. Screening for breast cancer. In: Di Guiseppi C, ed. Guide to Clinical Preventive Services. Baltimore: Williams & Wilkins; 1996:73–87.

    Google Scholar 

  61. Minton SE. Chemoprevention of breast cancer in the older patient. Hematol Oncol Clin N Am. 2000;14:113–130.

    Article  CAS  Google Scholar 

  62. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879–1886.

    PubMed  CAS  Google Scholar 

  63. Cummings SR, Eckert S, Krueger KA, et al. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. JAMA. 1999;281(23):2189–2197.

    Article  PubMed  CAS  Google Scholar 

  64. Kiningham RB. Physical activity and the primary prevention of cancer. Prim Care. 1998;25(2):515–536.

    PubMed  CAS  Google Scholar 

  65. Flood AB, Wennberg JE, Nease RF, Fowler FJ, Ding J, Hynes LM. The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team. J Gen Intern Med. 1996;11: 342–349.

    PubMed  CAS  Google Scholar 

  66. Friedrich MJ, Issues in prostate cancer screening. JAMA. 1999;281:1573–1575.

    Article  PubMed  CAS  Google Scholar 

  67. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services. Baltimore: Williams & Wilkins; 1996.

    Google Scholar 

  68. Martinez de Hurtado J, Chechile Toniolo G, Villavicencio Mavrich H. The digital rectal exam, prostate-specific antigen and transrectal echography in the diagnosis of prostatic cancer. Arch Esp Urol. 1995;48(3):247–259.

    PubMed  CAS  Google Scholar 

  69. De Parle N. From the Health Care Financing Administration. JAMA. 2000;283(12):1558.

    Article  Google Scholar 

  70. Siegler EE. Cervical carcinoma in the aged. Am J Obstet Gynecol. 1969;103:1093–1097.

    PubMed  CAS  Google Scholar 

  71. Mandelblatt JS, Hammond DB. Primary care of elderly women: is Pap smear screening necessary? Mt Sinai J Med. 1985;52:284–290.

    PubMed  CAS  Google Scholar 

  72. U.S. Preventive Services Task Force. Guidelines from Guide to Clinical Preventive Services, 2nd Ed. Baltimore: Williams & Wilkins; 1996.

    Google Scholar 

  73. Cervical cancer. NIH Consens Statement. 1996; 14(1):1–38.

    Google Scholar 

  74. Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med. 2000;132:810–819.

    PubMed  CAS  Google Scholar 

  75. U.S. Preventive Services Task Force. Screening for hypertension. In: Guide to Clinical Preventive Services. Baltimore: Williams & Wilkins; 1996:39–51.

    Google Scholar 

  76. Gorelick PB, Sacco RL, Smith DB, et al. Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA. 1999;281:1112–1120.

    Article  PubMed  CAS  Google Scholar 

  77. Mulrow CD, Cornell JA, Herrera CR, Kadri A, Farnett L, Aguilar C. Hypertension in the elderly. Implications and generalizability of randomized trials. JAMA. 1994;272: 1932–1938.

    Article  PubMed  CAS  Google Scholar 

  78. U.S. Preventive Services Task Force. Screening for hypertension. In: Guide to Clinical Preventive Services. Baltimore: Williams & Wilkins; 1996:39–51

    Google Scholar 

  79. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program. JAMA. 1991;245: 3255–3264.

    Google Scholar 

  80. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The National Heart, Lung, and Blood Institute (NHLBI). Bethesda: National Institutes of Health; 1997.

    Google Scholar 

  81. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program. JAMA. 1991;245:3255–3264.

    Google Scholar 

  82. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Dection, Evaluation, and Treatment of High Blood Pressure. NIH Pub: 93–1088. Bethesda: National Institutes of Health, 1993.

    Google Scholar 

  83. Corti MC, Guralnik JM, Salive ME, et al. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med. 1997;126:753–760.

    PubMed  CAS  Google Scholar 

  84. U.S. Preventive Services Task Force. Screening for Lipid Disorders: Recommendations and Rationale. Am J Prev Med. 2001;20(3S):73–76 (http://www.elsevier.com/locate/ajpmonline).

    Google Scholar 

  85. Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. American College of Physicians. Part 1. Ann Intern Med. 1996;124(5):515–517.

    Google Scholar 

  86. Garber AM, Browner WS, Hulley SB. Cholesterol screening in asymptomatic adults, revisited. Part 2. Ann Intern Med. 1996;124(5):518–531.

    PubMed  CAS  Google Scholar 

  87. Leaf DA. Lipid disorders: applying new guidelines to your older patients. Geriatrics. 1994;49(5):35–41.

    PubMed  CAS  Google Scholar 

  88. Ginsberg HN, Goldberg IJ. Disorders of lipoprotein metabolism. In: Harrison’s Principles of Internal Medicine. McGraw-Hill, New York, 2001.

    Google Scholar 

  89. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–2497.

    Google Scholar 

  90. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537–544.

    PubMed  CAS  Google Scholar 

  91. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–1350.

    Article  PubMed  CAS  Google Scholar 

  92. U.S. Department of Health and Human Services, Diabetes Prevention Program. Information available online: http://www.hhs.gov/news/press/2001pres/20010808a.html.

  93. Goldberg TH, Chavin SI, Preventive medicine and screening in older adults. J Am Geriatr Soc. 1997;45:344–354.

    PubMed  CAS  Google Scholar 

  94. Butler RN, Rubenstein AH, Gracia AM, Zweig SC. Type 2 diabetes: causes, complications, and new screening recommendations. I. Geriatrics. 1998;53(3): 47–50, 53–54.

    PubMed  CAS  Google Scholar 

  95. Goldberg TH, Chavin SI. Preventive medicine and screening in older adults. J Am Geriatr Soc. 1997;45:344–354.

    PubMed  CAS  Google Scholar 

  96. Goldberg TH. Update: Preventive medicine and screening in older adults. J Am Geriatr Soc. 1999;47:122–123.

    PubMed  CAS  Google Scholar 

  97. Association AD. Report of expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183–1197.

    Google Scholar 

  98. Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA. 2001; 286(22):2815–2822.

    Article  PubMed  CAS  Google Scholar 

  99. U.S. Preventive Services Task Force. Guidelines Guide to Clinical Preventive Services, 2nd Ed. Section I. Screening Part H. Musculoskeletal Disorders; Section III, Immunizations and Chemoprophylaxis. Baltimore: Williams & Wilkins; 1996.

    Google Scholar 

  100. Panel NCD. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285:785–795.

    Article  Google Scholar 

  101. Hough S. Osteoporosis clinical guideline. South African Medical Association—Osteoporosis Working Group. S Afr Med J. 2000;90(9 pt 2):907–944.

    PubMed  CAS  Google Scholar 

  102. Goldberg TH. Update: Preventive medicine and screening in older adults. J Am Geriatr Soc. 1999;47:122–123.

    PubMed  CAS  Google Scholar 

  103. Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321–333.

    Article  Google Scholar 

  104. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280:605–613.

    Article  PubMed  CAS  Google Scholar 

  105. Grady D, Herrington D, Bittner V. Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II). JAMA. 2002;288:49–57.

    Article  PubMed  Google Scholar 

  106. Hulley S, Furberg C, Barrett-Connor E. Non-cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and Estrogen/Progenstin Replacement Study Follow-up (HERS II). JAMA. 2002;288:58–66.

    Article  PubMed  CAS  Google Scholar 

  107. Reuben DB, Greendale GA, Harrison GG. Nutrition screening in older persons. J Am Geriatr Soc. 1995;43(4): 415–425.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Harrison G. Bloom
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Bloom, H.G. (2003). Prevention. In: Geriatric Medicine. Springer, New York, NY. https://doi.org/10.1007/0-387-22621-4_16

Download citation

  • DOI: https://doi.org/10.1007/0-387-22621-4_16

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-95514-8

  • Online ISBN: 978-0-387-22621-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation